Global glycomics market is projected to reach USD 2.0 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 13.8% from 2020 to 2025. North America is expected to dominate the global glycomics market, followed by Europe. The largest share of North America is mainly attributed to increasing funding on glycomics research, rising RD expenditure for drug discovery development, and the presence of all key players.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
The growth of this market is majorly driven by the increasing RD expenditure and funding for proteomics and glycomics research, growth of the proteomics market, and technological advancements in glycomics instrumentation.
Market Segmentation
The enzymes segment accounted for the largest share of the glycomics market, by product
The enzymes segment is expected to dominate the market and is projected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the consumable nature of enzymes and their wide applications in a variety of RD and drug discovery procedures.
Glycomics market for drug discovery development application is expected to grow at a high rate
Drug discovery development is the largest and the fastest-growing application segment in the glycomics market, majorly due to the increasing RD investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.
North America is the largest regional market for glycomics
The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa).
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
Key Market Players
The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L.
Report Objectives
- To define, describe, and forecast the global glycomics market based on product, application, end-user, and region
- To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, challenges, and opportunities)
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
- To profile key market players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions; new product launches; expansions; agreements, partnerships, and collaborations; and RD activities in the glycomics market
Get Free Customization @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132685525
